323 related articles for article (PubMed ID: 678030)
1. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase].
Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM
Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030
[TBL] [Abstract][Full Text] [Related]
2. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
[TBL] [Abstract][Full Text] [Related]
3. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
[TBL] [Abstract][Full Text] [Related]
4. [Genetic counseling in ornithine carbamoyltransferase deficiency].
Pelet A; Toumas E; Rabier D; Kaplan J; Kamoun P; Frezal J; Saudubray JM; Munnich A
Ann Biol Clin (Paris); 1988; 46(7):455-9. PubMed ID: 2903704
[TBL] [Abstract][Full Text] [Related]
5. Seven new mutations in the human ornithine transcarbamylase gene.
Tuchman M; Plante RJ; McCann MT; Qureshi AA
Hum Mutat; 1994; 4(1):57-60. PubMed ID: 7951259
[No Abstract] [Full Text] [Related]
6. Site specific screening for point mutations in ornithine transcarbamylase deficiency.
Feldmann D; Rozet JM; Pelet A; Hentzen D; Briand P; Hubert P; Largilliere C; Rabier D; Farriaux JP; Munnich A
J Med Genet; 1992 Jul; 29(7):471-5. PubMed ID: 1353535
[TBL] [Abstract][Full Text] [Related]
7. Carrier detection of urea cycle disorders.
Ng WG; Oizumi J; Koch R; Shaw KN; McLaren J; Donnel GN; Carter M
Pediatrics; 1981 Sep; 68(3):448-52. PubMed ID: 7279481
[No Abstract] [Full Text] [Related]
8. Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous females.
Oppliger Leibundgut E; Liechti-Gallati S; Colombo JP; Wermuth B
Hum Mutat; 1997; 9(5):409-11. PubMed ID: 9143919
[No Abstract] [Full Text] [Related]
9. Evidence for x-linked dominant inheritance of ornithine transcarbamylase deficiency.
Short EM; Conn HO; Snodgrass PJ; Campbell AG; Rosenberg LE
N Engl J Med; 1973 Jan; 288(1):7-12. PubMed ID: 4681915
[No Abstract] [Full Text] [Related]
10. Study of enzyme defect in a case of ornithine transcarbamylase deficiency.
Qureshi IA; Letarte J; Quellet R
Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890
[TBL] [Abstract][Full Text] [Related]
11. [DNA diagnosis of ornithine transcarbamylase deficiency by PCR method].
Matsuura T; Matsuda I
Tanpakushitsu Kakusan Koso; 1990 Dec; 35(17):3113-9. PubMed ID: 2287729
[No Abstract] [Full Text] [Related]
12. Ornithine transcarbamylase deficiency in mutant mice I. Studies on the characterization of enzyme defect and suitability as animal model of human disease.
Qureshi IA; Letarte J; Ouellet R
Pediatr Res; 1979 Jul; 13(7):807-11. PubMed ID: 481951
[No Abstract] [Full Text] [Related]
13. [Changes of urinary excretion of orotic acid in a patient with ornithine carbamyl transferase deficiency].
Sakane Y; Sugimoto T
Rinsho Byori; 1982 May; 30(5):547-50. PubMed ID: 7131821
[No Abstract] [Full Text] [Related]
14. A novel missense mutation in the exon containing the putative ornithine-binding domain of the OTC enzyme in a female.
Demmer LA; Kim JM; de Martinville B; Dowton SB
Hum Mutat; 1996; 7(3):279. PubMed ID: 8829665
[No Abstract] [Full Text] [Related]
15. Spontaneous animal models of ornithine transcarbamylase deficiency: studies on serum and urinary nitrogenous metabolites.
Qureshi IA; Letarte J; Ouellet R
Adv Exp Med Biol; 1982; 153():173-83. PubMed ID: 7164896
[No Abstract] [Full Text] [Related]
16. [Variability of enzyme activity and urinary orotic acid in ornithine transcarbamylase deficient spf/+ heterozygotic mice].
Qureshi IA; Letarte J; Lebel S; Ouellet R
Diabete Metab; 1986 Oct; 12(5):250-5. PubMed ID: 3803679
[TBL] [Abstract][Full Text] [Related]
17. Identification of a cytogenetic deletion and of four novel mutations (Q69X, I172F, G188V, G197R) affecting the gene for ornithine transcarbamylase (OTC) in Spanish patients with OTC deficiency.
Climent C; García-Pérez MA; Sanjurjo P; Ruiz-Sanz JI; Vilaseca MA; Pineda M; Campistol J; Rubio V
Hum Mutat; 1999 Oct; 14(4):352-3. PubMed ID: 10502831
[TBL] [Abstract][Full Text] [Related]
18. [Detection of female carriers of ornithine-carbamyl-transferase deficiency by measurement of orotic acid in the urine].
Dhondt JL; Farriaux JP
Lille Med; 1975 Oct; 20(8):727-30. PubMed ID: 1219292
[No Abstract] [Full Text] [Related]
19. Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.
Hoshide R; Matsuura T; Sagara Y; Kubo T; Shimadzu M; Endo F; Matsuda I
Am J Med Genet; 1996 Aug; 64(3):459-64. PubMed ID: 8862622
[TBL] [Abstract][Full Text] [Related]
20. [Trial of detection of female carriers for the ornithine-carbamyltransferase deficiency by the urine assay of crotic acid. Apropos of a family study].
Dhondt JL; Farriaux JP
Ann Genet; 1975 Sep; 18(3):197-202. PubMed ID: 1080984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
